Article
Brochure
Executive Resource
Video
Ext. Publication
Home /
Insights & Resources
Insights & Resources
Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.
- Alternative Investments
- Banking
- Blockchain & Digital Assets
- Construction
- Consumer Products
- Energy Transition
- Financial Services
- Food & Beverage
- General Business
- Government
- Health Care
- Higher Education
- Hospitality & Entertainment
- Industrial Products
- Insurance
- Life Sciences
- Not-for-Profit
- Oil & Gas
- Oilfield Services
- Real Estate
- Renewable Fuels
- Technology
- Transportation & Logistics
- Accounting Advisory
- Artificial Intelligence
- Asset Management Consulting
- Asset Tracing
- Cybersecurity
- Data Privacy
- Digital Transformation
- Energy Compliance
- ESG Strategy & Consulting
- Family Law
- Forensics & Litigation
- Government Consulting
- Health Care Valuation
- IT Advisory
- Risk Advisory
- Transaction Advisory
- Trust & Estate
- Valuation
PodcastLearn how artificial intelligence (AI) is reshaping cybersecurity in government, threats agencies face and best practices to protect critical data.
Explore how proposed Medicaid cuts could impact health care valuations, reimbursement models and financial stability across various provider segments.
Discover how outsourcing in pharmaceutical manufacturing enhances quality, ensures compliance and mitigates risks in a rapidly evolving industry.
Several updates to HB 8 will affect Texas community colleges and their state funding. Here’s the breakdown and how they will affect campuses.
Discover 10 surprising ways Texas’ rapid growth and advancements are reshaping industries, driving business innovation and creating new opportunities.
Explore key trends in government health care, from funding challenges to innovation, and how policies will shape the future of patient care.
Learn how HMRC's guidelines impact transfer pricing for life sciences and other multinationals and how to mitigate risks and ensure compliance.
Explore the myths, realities and the government’s role in providing mental health care with insights from Adam Jones and Dr. John Burruss.
Executive ResourceBoard members might consider how recent government activity, climate considerations and supply chain vulnerabilities will affect their businesses.
J.P. Morgan’s Q3 2024 Biopharma Report highlights robust venture investments, shifting licensing trends and a resurgence in IPO activity.
KPMG has released their 2024 biopharma report detailing the challenges and opportunities for pharma companies moving forward into the new year.
WebinarThis on-demand session provides insight into the best practices for financial reporting, compliance and internal controls, ensuring your organization remains transparent and accountable.